In the international export-import business competing currencies force the U.S. dollar higher, a dis...
Biotech ETF Trend Likely to Continue
08/15/2012 10:00 am EST
This high flyer shows no clear signs of stopping, although caution is always warranted, writes Frank Kollar.
Shares of the Market Vectors Biotech ETF (BBH) may have the reputation of being volatile, but for those looking for a strong current uptrend, BBH fits the bill.
Since hitting correction lows at $29.33 back on August 7, 2011, BBH has risen steadily over the past year to $49.66 as of Monday, August 13 near the close. This 69% gain puts the biotech sector near the top in performance.
There is still some volatility, and buyers of this ETF should be prepared for 5% to 8% pullbacks.
A trailing stop around 10% should protect against a further corrective movement. Even lower risk would be had with a stop at $47 a share, the July 24 correction low.
Frank Kollar can be found at FibTimer.com.
Related Articles on ETFs
One instrument of choice to profit from in a stock market sell-off is to buy the iShares 20+ Year Tr...
Often referred to as “Mr. Retirement,” Robert Powell is a long-time financial journalist...
The Invesco S&P SmallCap 600 Pure Value ETF (RZV) tracks a fundamentally weighted index of U.S.-...